the community will be more than 100,000 mammograms a year mobile screening units.
The Governing Council approved awarding 11.3 million contract management of this programme for the next four years.
-seven of every 10 cases of breast cancer that detects this program are at early stage
– with the program of early detection of breast cancer mammograms has been to more than one million women’s
Madrid, 2012-June the Governing Council approved awarding the Spanish Association against cancer the management of the public service contract to perform mammograms in mobile units for the next four years, amounting to EUR 11.3 million, within the program of early detection of the community of Madrid (DEPRECAM) breast cancer, as reported by the Vice-Chairman, spokesman for culture and sport and spokesman, Ignacio Gonzalez.
In total, it is estimated that during the term of the new contract was made around 105,000 explorations mamográficas year, which represent around 420,000 mammograms in the next four years.
These mobile facilities, the Ministry of health guarantees the greatest possible coverage by facilitating the realization of this essential test, displacing resources environments close to the residence of women recipients of the programme. He has in fact been detected in 70% of cases the tumor in its initial phase.
The community of Madrid reminds that the realization of the mammography is the most effective preventive measure for the detection and early treatment of breast cancer.
Breast cancer early detection program focuses on the realization, every two years, of a radiological examination of breast to all women aged between 50 and 69 years, ages in which breast cancer is the leading cause of mortality. Thanks to this program has been mammograms to more than one million women since it launched, and 0.5% of them were sent to diagnostic confirmation to a hospital because there was suspicion of malignancy.
Although breast cancer is tumor more frequent in Spanish women, 95% of the patients to them has been detected at early stage survive ten years after diagnosis.
In the community of Madrid, about 2,500 women receive this diagnosis every year. Despite its incidence, the mortality rate in the community of Madrid from this disease lies a point below the average of Spain, which is the lowest in the European Union. Thus in the Madrid Community rate is 17.3 deaths per 100,000 inhabitants, compared to 18.2 in Spain.